Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials
- PMID: 25995739
- PMCID: PMC4424245
- DOI: 10.5114/aoms.2015.50960
Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials
Abstract
Introduction: Many studies have shown that oral supplementation with astaxanthin may be a novel potential treatment for inflammation and oxidative stress in cardiovascular diseases, but evidence of the effects on lipid profile and glucose is still inconclusive. Therefore, we performed a meta-analysis to evaluate the efficacy of astaxanthin supplementation on plasma lipid and glucose concentrations.
Material and methods: The search included PubMed, Cochrane Library, Scopus, and EMBASE (up to November 27, 2014) to identify randomized controlled trials (RCTs) investigating the effects of astaxanthin supplementation on lipid profile and glucose levels. Two independent reviewers extracted data on study characteristics, methods and outcomes.
Results: Seven studies meeting inclusion criteria with 280 participants were selected for this meta-analysis; 163 participants were allocated to the astaxanthin supplementation group and 117 to the control group. A random-effect meta-analysis of data from 7 RCTs (10 treatment arms) did not show any significant effect of supplementation with astaxanthin on plasma concentrations of total cholesterol (weighted mean difference (WMD): -1.52 mg/dl, 95% CI: -8.69 to -5.66, p = 0.679), LDL-C (WMD: +1.25 mg/dl, 95% CI: -6.70 to +9.21, p = 0.758), HDL-C (WMD: +1.75 mg/dl, 95% CI: -0.92 to +4.42, p = 0.199), triglycerides (WMD: -4.76 mg/dl, 95% CI: -21.52 to +12.00, p = 0.578), or glucose (WMD: -2.65 mg/dl, 95% CI: -5.84 to +0.54, p = 0.103). All these effect sizes were robust, and omission of any of the included studies did not significantly change the overall estimate.
Conclusions: This meta-analysis of data from 10 RCT arms did not indicate a significant effect of supplementation with astaxanthin on plasma lipid profile, but a slight glucose-lowering effect was observed. Further, well-designed trials are necessary to validate these results.
Keywords: antioxidants; astaxanthin; glucose; lipids.
Figures
Similar articles
-
Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors--Results from a systematic review and meta-analysis of randomized controlled trials.Int J Cardiol. 2015;189:47-55. doi: 10.1016/j.ijcard.2015.04.008. Epub 2015 Apr 1. Int J Cardiol. 2015. PMID: 25885871 Review.
-
Effects of quercetin supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials.Crit Rev Food Sci Nutr. 2017 Mar 4;57(4):666-676. doi: 10.1080/10408398.2014.948609. Crit Rev Food Sci Nutr. 2017. PMID: 25897620 Review.
-
The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials.Pharmacol Res. 2016 Aug;110:76-88. doi: 10.1016/j.phrs.2016.04.021. Epub 2016 May 6. Pharmacol Res. 2016. PMID: 27157250 Review.
-
Lipid-modifying effects of krill oil in humans: systematic review and meta-analysis of randomized controlled trials.Nutr Rev. 2017 May 1;75(5):361-373. doi: 10.1093/nutrit/nuw063. Nutr Rev. 2017. PMID: 28371906 Review.
-
A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations.Clin Nutr. 2016 Aug;35(4):842-51. doi: 10.1016/j.clnu.2015.09.007. Epub 2015 Sep 25. Clin Nutr. 2016. PMID: 26433766 Review.
Cited by
-
More Than Pigments: The Potential of Astaxanthin and Bacterioruberin-Based Nanomedicines.Pharmaceutics. 2023 Jun 26;15(7):1828. doi: 10.3390/pharmaceutics15071828. Pharmaceutics. 2023. PMID: 37514016 Free PMC article. Review.
-
Effects of Astaxanthin supplementation on selected metabolic parameters, anthropometric indices, Sirtuin1 and TNF-α levels in patients with coronary artery disease: A randomized, double-blind, placebo-controlled clinical trial.Front Nutr. 2023 Mar 27;10:1104169. doi: 10.3389/fnut.2023.1104169. eCollection 2023. Front Nutr. 2023. PMID: 37051124 Free PMC article.
-
More Than an Antioxidant: Role of Dietary Astaxanthin on Lipid and Glucose Metabolism in the Liver of Rainbow Trout (Oncorhynchus mykiss).Antioxidants (Basel). 2023 Jan 6;12(1):136. doi: 10.3390/antiox12010136. Antioxidants (Basel). 2023. PMID: 36670998 Free PMC article.
-
Effectiveness of Dietary Supplement for Skin Moisturizing in Healthy Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Front Nutr. 2022 Jun 2;9:895192. doi: 10.3389/fnut.2022.895192. eCollection 2022. Front Nutr. 2022. PMID: 35719159 Free PMC article.
-
Astaxanthin Influence on Health Outcomes of Adults at Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis.Nutrients. 2022 May 13;14(10):2050. doi: 10.3390/nu14102050. Nutrients. 2022. PMID: 35631193 Free PMC article. Review.
References
-
- Zhao ZW, Cai W, Lin YL, et al. Ameliorative effect of astaxanthin on endothelial dysfunction in streptozotocin-induced diabetes in male rats. Arzneimittel-Forschung. 2011;61:239–46. - PubMed
-
- Boussiba S, Cohen Z, Richmond A, Vonshak A. Procedure for large-scale production of astaxanthin from Haematococcus; Google Patents; 2000.
-
- Choi HD, Kang HE, Yang SH, Lee MG, Shin WG. Pharmacokinetics and first-pass metabolism of astaxanthin in rats. Br J Nutrition. 2011;105:220–7. - PubMed
-
- Aoi W, Naito Y, Takanami Y, et al. Astaxanthin improves muscle lipid metabolism in exercise via inhibitory effect of oxidative CPT I modification. Biochem Biophys Res Comm. 2008;366:892–7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources